CD274 and metastatic neoplasm: Apart from its retrospective nature, our study presents some major limitations; almost 90% of our cohort had metastatic disease, which means that most of our analyzed samples were obtained by core or fine needle biopsy, and PD-L1 expression levels can vary significantly depending on the site of biopsy; thus, we might underestimate PD-L1.